Value-Based Radiation Oncology (VBRO) – is an ESTRO/ECF-HERO Project aimed at developing a framework to define the value and benefits of various technologies used in radiotherapy (RT).
The project intends to enable policymakers to prioritise and allocate funding more effectively toward innovations and existing treatments that have evidence of delivering meaningful benefits for patients.
Supported by a grant from Elekta and Varian, the VBRO Project seeks to enhance patient access to high-value developments in radiotherapy, thereby contributing to the overall improvement of healthcare systems.
The VBRO project will provide a framework to define value in radiation oncology (RO) by:
- Defining and categorize innovations in radiation oncology
- Defining endpoints needed for policy making in RO
- Linking endpoints and interventions with the evidence needed
- Providing a value framework, publications and communication collaterals (policy papers, key messages) for the RT community to adopt and the oncology community to acknowledge it, creating potential of impacting on HTA of RT innovations.
The VBRO Project work is embedded in the HERO (Health Economics of Radiation Oncology) project of the European Society for Radiotherapy and Oncology (ESTRO), launched in 2012 with the ambition to generate a model and knowledge base for health economics and health services research in radiation oncology [Lievens & Grau].
Click HERE to know more about the HERO Project
The project will run for 3 years and will conclude by providing a framework for VBRO in radiation oncology with policy implications.
Links to publications:
Value-based radiotherapy: A new chapter of the ESTRO-HERO project
Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink